Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,528 | 226 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,384 | 88 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $924.93 | 59 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $197.95 | 14 | $0 (2024) |
| Celgene Corporation | $186.28 | 13 | $0 (2024) |
| Janssen Biotech, Inc. | $143.24 | 8 | $0 (2024) |
| PFIZER INC. | $93.67 | 6 | $0 (2024) |
| Ardelyx, Inc. | $66.18 | 3 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $61.33 | 4 | $0 (2017) |
| Braintree Laboratories, Inc. | $58.83 | 4 | $0 (2022) |
| RedHill Biopharma Inc. | $54.92 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $596.81 | 36 | ABBVIE INC. ($235.00) |
| 2023 | $458.98 | 27 | AbbVie Inc. ($245.05) |
| 2022 | $772.31 | 49 | ABBVIE INC. ($297.57) |
| 2021 | $632.46 | 42 | AbbVie Inc. ($261.94) |
| 2020 | $267.80 | 19 | AbbVie Inc. ($117.63) |
| 2019 | $437.58 | 28 | AbbVie, Inc. ($205.12) |
| 2018 | $171.40 | 11 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($114.76) |
| 2017 | $190.97 | 14 | Valeant Pharmaceuticals North America LLC ($61.33) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: Immunology | ||||||
| 11/06/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: VIROLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/10/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/23/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: VIROLOGY | ||||||
| 09/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $13.69 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/23/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $17.43 | General |
| Category: VIROLOGY | ||||||
| 08/15/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/09/2024 | Echosens North America, Inc. | FibroScan (Device) | Food and Beverage | Cash or cash equivalent | $15.84 | General |
| Category: Elastography | ||||||
| 07/30/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: VIROLOGY | ||||||
| 07/22/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: IMMUNOLOGY | ||||||
| 07/11/2024 | ABBVIE INC. | CREON (Drug), VIBERZI, LINZESS | Food and Beverage | In-kind items and services | $28.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/21/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: VIROLOGY | ||||||
| 06/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.45 | General |
| Category: Neuroscience | ||||||
| 06/12/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Gastroenterology | ||||||
| 06/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/10/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/14/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: VIROLOGY | ||||||
| 05/08/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: IMMUNOLOGY | ||||||
| 05/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Gastroenterology | ||||||
| 04/25/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.57 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 730 | 826 | $381,914 | $64,652 |
| 2022 | 13 | 852 | 1,067 | $431,058 | $71,864 |
| 2021 | 15 | 734 | 894 | $365,647 | $62,899 |
| 2020 | 15 | 535 | 641 | $257,890 | $40,555 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 63 | 63 | $87,696 | $11,943 | 13.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 106 | 127 | $17,526 | $7,330 | 41.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 100 | 100 | $19,400 | $5,927 | 30.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 72 | 72 | $56,520 | $5,820 | 10.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 44 | 44 | $50,952 | $5,322 | 10.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 31 | 32 | $34,560 | $5,182 | 15.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 43 | 43 | $12,642 | $4,771 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 52 | 55 | $11,220 | $4,626 | 41.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 99 | 166 | $19,920 | $3,160 | 15.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 15 | 16 | $17,280 | $2,594 | 15.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $5,838 | $2,536 | 43.4% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 21 | $22,680 | $2,531 | 11.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 23 | 24 | $17,280 | $1,690 | 9.8% |
| 43450 | Dilation of esophagus | Facility | 2023 | 41 | 42 | $8,400 | $1,221 | 14.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 89 | 89 | $123,888 | $16,561 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 141 | 181 | $24,978 | $10,079 | 40.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 133 | 133 | $25,802 | $8,429 | 32.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 84 | 84 | $65,940 | $7,073 | 10.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 153 | 314 | $37,680 | $6,507 | 17.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 58 | 58 | $67,164 | $4,852 | 7.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 45 | 45 | $13,230 | $4,764 | 36.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 25 | 25 | $27,000 | $4,276 | 15.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 41 | $8,364 | $3,812 | 45.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $12,960 | $1,978 | 15.3% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 19 | 20 | $14,400 | $1,687 | 11.7% |
About Jenny Smith
Jenny Smith is a Gastroenterology healthcare provider based in Maryville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2007. The National Provider Identifier (NPI) number assigned to this provider is 1912115460.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jenny Smith has received a total of $3,528 in payments from pharmaceutical and medical device companies, with $596.81 received in 2024. These payments were reported across 226 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($3,528).
As a Medicare-enrolled provider, Smith has provided services to 2,851 Medicare beneficiaries, totaling 3,428 services with total Medicare billing of $239,969. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Maryville, TN
- Active Since 05/18/2007
- Last Updated 07/06/2016
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1912115460
Products in Payments
- XIFAXAN (Drug) $785.05
- MAVYRET (Drug) $501.81
- ENTYVIO (Biological) $186.98
- ZEPOSIA (Drug) $186.28
- RINVOQ (Biological) $161.11
- Humira (Biological) $149.02
- HUMIRA (Biological) $148.99
- LINZESS (Drug) $146.65
- REMICADE (Biological) $102.72
- TRULANCE (Drug) $90.01
- XELJANZ (Drug) $81.99
- CREON (Drug) $81.21
- UCERIS (Drug) $78.41
- SKYRIZI (Biological) $75.30
- IBSRELA (Drug) $66.18
- ZENPEP (Drug) $63.39
- VIBERZI (Drug) $56.10
- Talicia (Drug) $54.92
- OCALIVA (Drug) $52.61
- INJECTAFER (Drug) $41.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Maryville
Dr. William Lyles, Md, MD
Gastroenterology — Payments: $136,354
Dr. Sirisha Jasti, Md, MD
Gastroenterology — Payments: $8,224
Dr. Frank Wright, M.d, M.D
Gastroenterology — Payments: $8,206
Edmundo Rodriguez-Frias, Md, MD
Gastroenterology — Payments: $7,976
Dr. Jennifer Phemister, M.d, M.D
Gastroenterology — Payments: $5,666
Dr. Isaac Cline, M.d, M.D
Gastroenterology — Payments: $4,763